Skip to main content
. 2022 Jan 11;11:760655. doi: 10.3389/fonc.2021.760655

Table 4.

Treatment-related adverse events.

Toxicity Nab-paclitaxel (n = 79) Docetaxel (n = 80) χ2 P
Neutropenia 1.734 0.420
 0 11 8
 1–2 42 38
 3–4 26 34
Thrombocytopenia 2.484 0.289
 0 33 43
 1–2 39 30
 3–4 7 7
Nausea 2.941 0.230
 0 15 8
 1–2 37 38
 3–4 27 34
Oral mucositis 0.802 0.669
 0 44 46
 1–2 27 29
 3–4 8 5
Cardiotoxicity 1.097 0.578
 0 62 65
 1–2 16 15
 3–4 1 0
Peripheral sensory neuropathy 9.700 0.008
 0 31 51
 1–2 38 24
 3–4 10 5
Rash 1.574 0.455
 0 65 71
 1–2 12 7
 3–4 2 2
Arthralgia 6.123 0.047
 0 49 34
 1–2 26 39
 3–4 4 7